© 2022 MJH Life Sciences and Nutritional Outlook. All rights reserved.
© 2022 MJH Life Sciences™ and Nutritional Outlook. All rights reserved.
33 BREMERTON CIR
300 PASTEUR DR
September 19, 2011
Cardiovascular-health ingredients are probably the main beneficiaries of EFSA rulings. What is the significance of this, and what are the opportunities for the industry?